drugset / Trial / NCT01037699
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
RandomizedParallel-groupOpen-labelTreatment
Summary
To analyse the impact on cycle outcome of LH supplementation in ovarian stimulation controlled with a GnRH antagonist in two ages groups: patients upto 35 years old, and patients aged between 36 and 39 years old.
Timeline
- Start
- 2005-01
- Primary completion
- 2008-03
- Completion
- 2008-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Follicle Stimulating Hormone | Protein / enzyme biologic | 150 iu | — |
| Comparator | Follicle Stimulating Hormone | Protein / enzyme biologic | 225 iu | — |
| Comparator | Follicle Stimulating Hormone | Protein / enzyme biologic | 300 iu | — |
| Subject | Luteinizing Hormone | Protein / enzyme biologic | 75 iu | — |
Indications
No indication recorded.